No business profile yet.
Size Corporate Travel Management (CTD.AX) is an Australia Industrials company (Miscellaneous Commercial Services) with a market value of $350M, the 309th largest of 316 Australia companies the cockpit tracks. Shares closed at A$3.64 on 6 Nov 2026.
Performance Over six months the shares fell 68.9%, against -15.2% for the median peer and +4.1% for the Australia market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 6.8% over the last twelve months (peer median +5.7%); the operating margin is 6.5% (peer median 9.3%).
Valuation It trades at 19.5× forward earnings against a peer median of 17.0× (3rd most expensive of 15).
Price implies For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +31%, so the hurdle is -19 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 7.6 points below its cost of capital (13.3% WACC).
Next results Next results expected around 16 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | A$665M | A$660M | A$622M | A$621M | A$650M |
| Revenue growth | — | +6% | 0% | -5% | — |
| Gross profit | A$158M | A$185M | A$132M | A$132M | A$130M |
| EBITDA | A$100M | A$106M | A$64.3M | A$96.3M | A$158M |
| Net income | A$17.7M | A$17.7M | -A$349M | A$19.0M | A$77.6M |
| Free cash flow | A$25.5M | A$25.5M | A$140M | A$122M | A$76.0M |
| Capital expenditure | A$30.2M | A$30.2M | A$38.9M | A$47.6M | A$36.8M |
| Total debt | n/a | A$33.6M | A$27.7M | A$39.6M | A$38.4M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CTD.AX | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +59.6% | -1.5% | highest of 21 |
| 6-month return | -68.9% | -15.2% | lowest of 21 |
| Distance from 52-week high | -79.6% | -39.3% | lowest of 21 |
| Revenue growth (TTM) | +6.8% | +5.7% | 11th highest of 21 |
| Operating margin | 6.5% | 9.3% | 10th lowest of 21 |
| Forward P/E | 19.5× | 17.0× | 3rd most expensive of 15 |
| Growth the price implies (Req g, 7 yrs) | 12.0% | 7.1% | 3rd most demanding of 13 |
| Growth delivered (Del g) | +30.6% | +8.2% | 3rd highest of 13 |
| Hurdle (Req g minus delivered) | -18.6 pp | -7.4 pp | 4th least demanding of 13 |
| ROIC minus cost of capital | -7.6 pp | -2.7 pp | 6th lowest of 19 |
| EV / EBITDA | 4.5× | 10.5× | 2nd cheapest of 13 |
| Net debt / EBITDA | -0.7× | -0.8× | 7th least indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Corporate Travel Management CTD.AX | Australia | $350M | -69% | +7% | 6% | 19.5× | 12.0% | +30.6% |
| Zhejiang Xidamen New Material 605155.SS | China | $349M | -23% | +4% | 12% | 15.7× | -0.9% | +20.0% |
| Shenzhen Ridge Technology 300977.SZ | China | $349M | -27% | +13% | -2% | 31.9× | 33.2% | -4.0% |
| Avacta AVCT.L | United Kingdom | $352M | -24% | -100% | -27,388% | n/a | n/a | n/a |
| Insource 6200.T | Japan | $347M | -1% | +7% | 40% | 11.1× | n/a | n/a |
| Ningbo Color Master Batch 301019.SZ | China | $354M | -31% | +14% | 21% | n/a | 10.4% | +1.8% |
| Tianjin LVYIN Landscape & Ecology Construction 002887.SZ | China | $354M | -41% | -8% | 12% | 17.1× | 11.3% | -13.0% |
| Takara & 7921.T | Japan | $346M | +23% | +4% | 15% | n/a | -11.6% | +4.7% |
| Qingdao Greensum Ecology 300948.SZ | China | $357M | -30% | +83% | -30% | n/a | n/a | n/a |
| Jiayuan Science And Technology 301117.SZ | China | $358M | -57% | -41% | -67% | 26.0× | n/a | n/a |
| Pico Far East 0752.HK | Hong Kong | $342M | -14% | +3% | 6% | n/a | n/a | n/a |
| Shin Nippon Biomedical Laboratories 2395.T | Japan | $360M | -5% | +2% | 10% | 14.5× | 6.9% | +16.6% |
| ECOPRO HN 383310.KS | South Korea | $360M | -27% | -27% | 9% | 17.5× | n/a | n/a |
| Roma Green Finance ROMA | United States | $360M | -1% | -22% | -315% | n/a | n/a | n/a |
| Optima Health OPT.L | United Kingdom | $361M | +29% | +15% | 3% | 18.8× | 29.6% | +1.5% |
| Globe-Ing 277A.T | Japan | $361M | -16% | +31% | 34% | 16.8× | -3.6% | +31.2% |
| Elixirr International ELIX.L | United Kingdom | $340M | -29% | +29% | 21% | 7.7× | 4.4% | +37.6% |
| Hargreaves Services HSP.L | United Kingdom | $363M | +8% | +33% | 4% | 18.0× | 9.2% | +11.4% |
| Keystone Law KEYS.L | United Kingdom | $335M | +38% | +21% | 9% | 18.5× | 7.3% | +15.9% |
| Omni Bridgeway OBL.AX | Australia | $367M | +8% | +75% | -15% | 9.7× | n/a | n/a |
| Hackett HCKT | United States | $334M | +25% | -8% | 13% | 8.7× | -1.2% | +5.0% |